Related Experiment Video
Updated: Feb 8, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
The HEART Pathway Randomized Controlled Trial One-year Outcomes
Jason P Stopyra1, Robert F Riley2, Brian C Hiestand1
1Department of Emergency Medicine, Wake Forest School of Medicine, Winston-Salem, NC.
Insights
The HEART Pathway demonstrated a 100% negative predictive value for major adverse cardiac events at one year in chest pain patients. This approach did not increase healthcare utilization, offering a safe and effective alternative to usual care.
Area of Science:
- Cardiology
- Emergency Medicine
- Health Services Research
Background:
- Acute chest pain is a common emergency department presentation requiring accurate risk stratification.
- The HEART score and serial troponin measurements are established tools for assessing cardiac risk.
- Optimizing diagnostic pathways can improve patient outcomes and healthcare resource utilization.
Purpose of the Study:
- To evaluate the impact of the HEART Pathway on healthcare utilization and safety outcomes.
- To assess the 1-year incidence of major adverse cardiac events (MACE) in patients managed with the HEART Pathway versus usual care.
- To determine the negative predictive value of the HEART Pathway for safety outcomes.
Main Methods:
- A randomized controlled trial involving 282 adult emergency department patients with chest pain.
- Patients were assigned to either the HEART Pathway (using HEART score and troponin) or usual care.
- Outcomes including MACE, objective testing, hospitalizations, and ED visits were assessed at 1 year.
Main Results:
- No significant difference in 1-year MACE rates between the HEART Pathway (9.9%) and usual care (11.3%).
- The HEART Pathway achieved 100% negative predictive value for MACE in low-risk patients.
- Objective testing and cardiac-related healthcare utilization showed non-significant trends between groups.
Conclusions:
- The HEART Pathway is a safe strategy for managing acute chest pain patients, offering 100% NPV for 1-year MACE.
- It does not lead to increased downstream hospitalizations or emergency department visits.
- Further research may explore optimizing objective testing within this pathway.
Objective:
The objective was to determine the impact of the HEART Pathway on health care utilization and safety outcomes at 1 year in patients with acute chest pain.
Methods:
Adult emergency department (ED) patients with chest pain (N = 282) were randomized to the HEART Pathway or usual care. In the HEART Pathway arm, ED providers used the HEART score and troponin measures (0 and 3 hours) to risk stratify patients. Usual care was based on American College of Cardiology/American Heart Association guidelines. Major adverse cardiac events (MACE-cardiac death, myocardial infarction [MI], or coronary revascularization), objective testing (stress testing or coronary angiography), and cardiac hospitalizations and ED visits were assessed at 1 year. Randomization arm outcomes were compared using Fisher's exact tests.
Results:
A total of 282 patients were enrolled, with 141 randomized to each arm. MACE at 1 year occurred in 10.6% (30/282): 9.9% in the HEART Pathway arm (14/141; 10 MIs, four revascularizations without MI) versus 11.3% in usual care (16/141; one cardiac death, 13 MIs, two revascularizations without MI; p = 0.85). Among low-risk HEART Pathway patients, 0% (0/66) had MACE, with a negative predictive value (NPV) of 100% (95% confidence interval = 93%-100%). Objective testing through 1 year occurred in 63.1% (89/141) of HEART Pathway patients compared to 71.6% (101/141) in usual care (p = 0.16). Nonindex cardiac-related hospitalizations and ED visits occurred in 14.9% (21/141) and 21.3% (30/141) of patients in the HEART Pathway versus 10.6% (15/141) and 16.3% (23/141) in usual care (p = 0.37, p = 0.36).
Conclusions:
The HEART Pathway had a 100% NPV for 1-year safety outcomes (MACE) without increasing downstream hospitalizations or ED visits. Reduction in 1-year objective testing was not significant.
Related Concept Videos
Clinical Trials: Overview
Trial and Error and Algorithm
Clinical Trials
There are four phases in a clinical trial. A phase one...
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Random Error

